SMTL ID : 3wn5.2 (1 other biounit)

Crystal structure of asymmetrically engineered Fc variant in complex with FcgRIIIa

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.78 Å

Oligo State

hetero-1-1-1-mer

Ligands

1 x NAG- NAG- BMA- MAN- NAG- MAN- NAG- FUL: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-2)-alpha-D-mannopyranose-(1-3)-[2-acetamido-2-deoxy-beta-D-glucopyranose-(1-2)-alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[beta-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose

NAG-NAG-BMA-MAN-NAG-MAN-NAG-FUL.1: 14 residues within 4Å: Chain A: L.19, F.26, F.28, K.31, T.45, V.47, V.49, D.50, Q.80, Y.81, N.82, T.84, R.86, E.119 3 PLIP interactions: 3 interactions with chain A Hydrogen bonds: A:Y.81, A:R.86, A:K.31, A:K.31, A:R.86

1 x NAG- NAG- BMA- MAN- NAG- GAL- MAN- NAG- FUL: beta-D-galactopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-2)-alpha-D-mannopyranose-(1-6)-[2-acetamido-2-deoxy-beta-D-glucopyranose-(1-2)-alpha-D-mannopyranose-(1-3)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[beta-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose(Non-functional Binders)

NAG-NAG-BMA-MAN-NAG-GAL-MAN-NAG-FUL.2: 16 residues within 4Å: Chain B: M.24, V.25, F.26, F.28, P.29, K.31, E.43, T.45, V.47, V.49, D.50, N.82, T.84, R.86, K.119 Chain C: Y.133 4 PLIP interactions: 4 interactions with chain B Hydrogen bonds: B:V.25, B:F.28, B:E.43, B:E.43, B:T.45

1 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)

NAG-NAG.3: 4 residues within 4Å: Chain C: H.45, N.46, D.65, S.67 1 PLIP interactions: 1 interactions with chain C Hydrogen bonds: C:D.65

9 x IOD: IODIDE ION(Non-functional Binders)

IOD.4: 3 residues within 4Å: Chain A: K.199, W.202, Q.203 Ligand excluded by PLIP IOD.5: 4 residues within 4Å: Chain A: S.139, C.141 Chain B: T.135, K.224 Ligand excluded by PLIP IOD.6: 2 residues within 4Å: Chain B: M.37, S.39 Ligand excluded by PLIP IOD.7: 2 residues within 4Å: Chain B: V.25, K.119 Ligand excluded by PLIP IOD.8: 1 residues within 4Å: Chain B: K.33 Ligand excluded by PLIP IOD.10: 4 residues within 4Å: Chain C: R.19, Q.95, A.96, W.99 Ligand excluded by PLIP IOD.11: 3 residues within 4Å: Chain C: E.47, E.69, R.71 Ligand excluded by PLIP IOD.12: 1 residues within 4Å: Chain C: Y.34 Ligand excluded by PLIP IOD.13: 3 residues within 4Å: Chain A: K.115 Chain C: G.90, W.91 Ligand excluded by PLIP

1 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)

NAG.9: 3 residues within 4Å: Chain C: N.163, V.164, S.165 No protein-ligand interaction detected (PLIP)

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Mimoto, F. et al., Crystal structure of a novel asymmetrically engineered Fc variant with improved affinity for Fc gamma Rs. Mol.Immunol. (2014)

Release Date

2014-11-19

Peptides

Ig gamma-1 chain C region: A
Ig gamma-1 chain C region: B
Low affinity immunoglobulin gamma Fc region receptor III-A: C

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
D

B
E

C
F

Ig gamma-1 chain C region

Ig gamma-1 chain C region

Low affinity immunoglobulin gamma Fc region receptor III-A

Related Entries With Identical Sequence